Combination of Ibrutinib and Nivolumab Overcomes Ibrutinib Resistance in a Novel Patient-Derived Mantle Cell Lymphoma 3D Model

Ferran Araujo‐Ayala, Patricia Pérez‐Galán, Juan García Valero et al.|Blood|2022

Cited by 1